Lee Ainslie’s MiMedx Group MDXG Stock Holding History

Lee Ainslie’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-35,696	Closed	-$216K	–	513
2021 Q3	$216K	Buy	+35,696	New	+$402K	﹤0.01%	528

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

Lee Ainslie's MDXG Position: Q4 2021 in Review

Lee Ainslie sold out of MiMedx Group (MDXG) in Q4 2021, closing a stake of 35,696 shares — an estimated $216K sold.

Lee Ainslie first reported a position in MDXG in Q3 2021 and held it in 1 quarter. The position peaked at $216K in Q3 2021. 152 funds tracked by Wall St. Rank hold MDXG as of Q4 2021.

Lee Ainslie reported no remaining MiMedx Group position as of Q4 2021 after selling out during the quarter.
Lee Ainslie sold 35,696 MiMedx Group shares in Q4 2021, an estimated $216K.
Lee Ainslie first reported a position in MiMedx Group in Q3 2021 and held it in 1 quarter.
Lee Ainslie's MiMedx Group position peaked at $216K in Q3 2021.
152 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2021.

Based on Maverick Capital's 13F filing for Q4 2021, filed 14 Feb 2022.